International journal of hematology · 1995
Synchronous presentation of Epstein-Barr virus-associated Hodgkin's disease and adult T-cell leukemia/lymphoma (ATLL) in a patient from an endemic area of ATLL.
Клинический случайСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hayashi T, Yamabe H, Haga H, Akasaka T, Kadowaki N, Ohno H, Okuma M, Fukuhara S
Аннотация
We report a patient from an endemic area of adult T-cell leukemia/lymphoma (ATLL), who developed lymphoma with features characteristic of Hodgkin's disease (HD). Large atypical Reed-Sternberg/Hodgkin's cells (RS/H cells) had a CD3-CD15+CD20-CD30+CD45RO- immunophenotype. Epstein-Barr virus (EBV) latent membrane protein and EBV-encoded small RNA were detected in the RS/H cells. The patient received C-MOPP/ABVD chemotherapy for the HD resulting in a partial response. However, relapse occurred and he died of disease progression associated with serious bacterial infection. Although serial lymph node biopsies revealed consistent presence of the EBV-positive RS/H cells, the background small lymphocytes showed progressive increase in pleomorphism and nuclear irregularity. The lymphocytes had the T-cell phenotype, CD3+CD4+CD7-CD8-. Southern blot analysis using DNA probes for the human T-cell lymphotrophic virus-I (HTLV-I) and the T-cell receptor beta-chain gene demonstrated expansion of the HTLV-I infected monoclonal T-cells with the disease progression. We concluded that the patient synchronously presented two independent lymphoproliferative disorders; EBV-associated HD and ATLL resulting from HTLV-I infection.
Предметные рубрики MeSH
Antigens, CDAntineoplastic Combined Chemotherapy ProtocolsBleomycinCyclophosphamideDacarbazineDoxorubicinFatal OutcomeHerpesviridae InfectionsHerpesvirus 4, HumanHodgkin DiseaseHuman T-lymphotropic virus 1HumansImmunophenotypingJapanLeukemia-Lymphoma, Adult T-CellLymph NodesMaleMiddle AgedNeoplastic Stem CellsPrednisoneProcarbazineRNA, ViralReed-Sternberg CellsTumor Virus InfectionsVinblastineVincristineViral Matrix ProteinsVirus Activation